Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Rodent-borne diseases and their risks for public health
2009 Standout
In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics
2006
Junín Virus Infection of Human Hematopoietic Progenitors Impairs In Vitro Proplatelet Formation and Platelet Release via a Bystander Effect Involving Type I IFN Signaling
2010
Genetic diversity, clonality and sexuality in Toxoplasma gondii
2004
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
The Fear of COVID-19 Scale: Development and Initial Validation
2020 Standout
Mechanisms of Pathogenesis, Infective Dose and Virulence in Human Parasites
2012
Toxoplasma gondii infection in humans and animals in the United States
2008 Standout
Pharmacologic Optimization of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors (POPIN)-A Randomized Controlled Trial of Therapeutic Drug Monitoring and Adherence Support
2006
Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
2002 Standout
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
2009
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
2017 Standout
New opportunities for field research on the pathogenesis and treatment of Lassa fever
2007
RNA‐Mediated Inhibition of HIV in a Gene Therapy Setting
2003
The 1995 Kikwit Ebola outbreak: lessons hospitals and physicians can apply to future viral epidemics
2008
Melioidosis
2012 Standout
HLA-B*5701 Screening for Hypersensitivity to Abacavir
2008 Standout
Transmission of Herpes Simplex Virus Type 2 among Factory Workers in Ethiopia
2004
Drug Interactions with Bacillus anthracis Topoisomerase IV: Biochemical Basis for Quinolone Action and Resistance
2011
Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis
2020 Standout
Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague
2010 StandoutNobel
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
2001
Brucellosis: A re-emerging zoonosis
2009 Standout
Severe pneumonia during primary infection with an atypical strain of Toxoplasma gondii in an immunocompetent young man
2005
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy
2006
Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 Infection<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2006
Plague
2007
Psychosocial consequences of infectious diseases
2009
Gene therapy for HIV infection: what does it need to make it work?
2006 StandoutNobel
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Biological weapons
2006
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Antiretroviral Treatment for Adult HIV Infection in 2002
2002
Human brucellosis
2007 Standout
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
2005 Standout
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
Revealing the world of RNA interference
2004 StandoutNatureNobel
The bacterial gene lfpA influences the potent induction of calcitonin receptor and osteoclast-related genes in Burkholderia pseudomallei-induced TRAP-positive multinucleated giant cells
2006
Approach to the Treatment-experienced patient
2005
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
A tracing tool portfolio to detect Bacillus anthracis, Clostridium botulinum and Noroviruses: Bioterrorism is a food safety and security issue
2010
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
The acute respiratory distress syndrome
2012 Standout
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study
2009
Functional Expression and Localization of P-glycoprotein in the Central Nervous System: Relevance to the Pathogenesis and Treatment of Neurological Disorders
2004
Mechanism of Quinolone Action and Resistance
2014 Standout
Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review
2018 Standout
A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential
2007 Standout
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Fingerprinting food: current technologies for the detection of food adulteration and contamination
2012 Standout
Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma
2005
Therapeutic drug monitoring of antiretrovirals for people with HIV
2009
Rapid Detection and Quantification of Chikungunya Virus by a One-Step Reverse Transcription–Polymerase Chain Reaction Real-Time Assay
2007
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
2012
In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax
2005
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Psychosocial effects of an Ebola outbreak at individual, community and international levels
2016 Standout
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China
2020 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza
2010
Works of P Bossi being referenced
Atypical Toxoplasmic Manifestation after Discontinuation of Maintenance Therapy in a Human Immunodeficiency Virus Type 1-Infected Patient with Immune Recover
2003
Actualités sur les traitements antirétroviraux
2001
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy*
2004
Discontinuation of Secondary Prophylaxis against Disseminated Mycobacterium avium Complex Infection and Toxoplasmic Encephalitis
2002
P‐glycoprotein in blood CD4 cells of HIV‐1‐infected patients treated with protease inhibitors
2003
Hypersensitivity Syndrome Associated with Efavirenz Therapy
2000
Biological weapons
2006
[Genital herpes: epidemiology, transmission, clinic, asymptomatic viral excretion, impact on other sexually transmitted diseases, prevention, and treatment].
2002
Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax
2004
Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses
2004
Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis
2004
Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis
2004
Bichat guidelines for the clinical management of plague and bioterrorism-related plague
2004
Cases of chikungunya fever imported from the islands of the South West Indian Ocean to Paris, France
2007
Early Virological Failure in Naive Human Immunodeficiency Virus Patients Receiving Saquinavir (Soft Gel Capsule)-Stavudine-Zalcitabine (MIKADO Trial) Is Not Associated with Mutations Conferring Viral Resistance
2000